Mandeep Bajaj, MBBS, shared the path through Northern Ireland, India, and the U.S. that led to a career focus on hepatic fat, liver fibrosis, and what is now known as metabolic dysfunction-associated steatohepatitis (MASH).
With more incretin therapies anticipated for diabetes and obesity soon, experts including Maureen Chomko, RD, CDCES, discussed how dietitians and certified diabetes care and education specialists (CDCES) can help patients get the most benefit from these agents.
Time-restricted eating has been found to improve cardiometabolic health, insulin resistance, glycemic management, and blood pressure independent of weight loss. It can even affect polycystic ovary syndrome (PCOS), explained Sofia Cienfuegos, PhD, MS.
On the final day of the 84th Scientific Sessions, the Exhibit Hall and Poster Hall are open until 2:00 p.m. Poster presenters will again be available for discussion during the General Poster Session, and the Shop ADA store will be open for purchases.
Developed by leading investigators in the field in a closed-door expert forum earlier in the week, the program will take a bench-to-bedside perspective, reviewing what is currently known and identify knowledge gaps with the aim of spurring future research and translation of emerging concepts.
The ADA’s Outstanding Educator in Diabetes for 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, had his understanding of the disease reframed when he was diagnosed with type 1 diabetes as a graduate student.
Patti Urbanski, MEd, RD, LD, CDCES, FADCES, highlighted research on the effectiveness of diabetes education, weaving in her personal experience as a person with type 1 diabetes and as a diabetes educator.
Semaglutide is best known as a weight loss drug, yet SELECT was not a weight loss study. It was a secondary cardioprevention trial, explained Donna H. Ryan, MD, one of the experts presenting results from SELECT.
The drug has been shown to improve sleep apnea severity and related cardiometabolic issues in people with moderate-to-severe obstructive sleep apnea, reported investigators including Atul Malhotra, MD, and Louis J. Aronne, MD, FACP, DABOM.
Study Chair Irl B. Hirsch, MD, reported that inhaled insulin may be good for patients who are engaged in their diabetes self-management and want to reduce hyperglycemia even further, and for patients who want an alternative to a pump.